With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1122-10-7,3,4-Dibromo-1H-pyrrole-2,5-dione,as a common compound, the synthetic route is as follows.
To a stirred solution of 2,3-dibromomaleimide 3 [32] (255 mg, 1.0 mmol) in CH2Cl2 (20 mL)Et3N (279mL, 2.0 mmol) and n-butyl-mercaptan (226 ml, 2.1 mmol)were added under an argon atmosphere and stirred for 3 h at roomtemperature. The reaction mixture was evaporated, and the crudeproduct was purified by flash chromatography (hexanes:acetone 9:1) to give the desired compound 5a (243 mg, 89%)as a yellow powder. 1H NMR (400 MHz, CDCl3): d 8.07 (s, 1H, NH),3.29 (t, J 7.3 Hz, 4H, 2 x S-CH2), 1.69e1.58 (m, 4H), 1.52e1.35 (m,4H), 0.93 (t, J 7.3 Hz, 6H, 2 x CH3). 13C NMR (101 MHz, CDCl3):d 166.7 (2C, 2x CO); 136.8 (CC); 32.6, 31.6, 21.7 (6C, 6x CH2); 13.7(2C, 2x CH3). MS (ESI): m/z calculated for C12H19NO2S2 Na[M Na]: 296.075. Found: 296.073.
1122-10-7, As the paragraph descriping shows that 1122-10-7 is playing an increasingly important role.
Reference£º
Article; Sz?cs, Zsolt; Kelemen, Viktor; Le Thai, Son; Csavas, Magdolna; R?th, Erzsebet; Batta, Gyula; Stevaert, Annelies; Vanderlinden, Evelien; Naesens, Lieve; Herczegh, Pal; Borbas, Aniko; European Journal of Medicinal Chemistry; vol. 157; (2018); p. 1017 – 1030;,
Pyrroline – Wikipedia
1-Pyrroline | C4H7N – PubChem